SKI-O-703 capsule

DRUG2 trials

Sponsors

Oscotec Inc.

Conditions

Arthritis, RheumatoidRheumatoid Arthritis

Phase 1

Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers

CompletedNCT02717988

Oscotec Inc.Rheumatoid Arthritis

Start: 2015-09-30End: 2016-03-31Updated: 2018-02-28

Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of SKI-O-703 in Healthy Volunteers

CompletedNCT03315494

Oscotec Inc.Arthritis, Rheumatoid

Start: 2016-09-22End: 2016-12-21Updated: 2017-10-20